Medical International Technology reports on progress in China

Medical International Technology Inc. (MDLH.OB) www.mitneedlefree.com is pleased to announce its progress in China.

The first clinical trial required towards obtaining the Chinese FDA approval was completed last June. The second and final trial was recently completed successfully and MIT China received the final report from the two hospitals involved in the trial. The complete report has been submitted to the Chinese FDA authorities for final approval and issuance of the official licence to sell MIT Med-Jets, which is anticipated to begin within 4 to 6 weeks.

MIT President and CEO, Mr Karim Menassa would like to officially congratulate his Chinese partners, all the employees of MIT China, as well as all the dedicated people that helped us reach such a challenging and important milestone in a very short time. MIT now anticipates sales to grow at a fast pace starting in November 2010.

Vice-President and Chief Strategic Officer, Dr Francis Bellido said: "The first accomplishment of the company's three priorities for 2010 will increase our visibility and raise awareness about MIT Canada's unique needle-free technology and products. Moreover, our second and third priorities are underway with completion expected by the end of 2010".

Mr. Harold Gervais, CFO of MIT has completed his mandate and realized the main objectives assigned to him when he joined MIT on a part time basis in January 2010. Mr Gervais will remain on the advisory board and will be available to head various initiatives as the company grows.

Medical International Technology Inc. is proud to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.